Response to Comment on “Tacrolimus Drug-Drug Interaction with Nirmatrelvir/Ritonavir (Paxlovid™) Managed with Phenytoin”

被引：0
|
作者：
Morganne Sindelar
Daniel McCabe
Elisabeth Carroll
机构：
[1] The University of Iowa Hospitals & Clinics,Division of Medical Toxicology, Department of Emergency Medicine
[2] The University of Iowa Hospitals & Clinics,undefined
来源：
Journal of Medical Toxicology | 2023年 / 19卷
关键词：
Drug-drug interaction; Tacrolimus; Nirmatrelvir/ritonavir;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：309 / 309
相关论文
共 50 条
  • [11] Leucovorin-phenytoin: A drug-drug interaction? Comment
    Tidwell, BH
    Cleary, JD
    ANNALS OF PHARMACOTHERAPY, 1995, 29 (12) : 1303 - 1304
  • [12] Paxlovid and tacrolimus drug interaction
    Reactions Weekly, 2023, 1951 (1) : 5 - 5
  • [13] A biological pharmacology network to secure the risk of drug-drug interaction with nirmatrelvir/ritonavir
    Lemaitre, F.
    Boland, L.
    Tron, C.
    Ruelland, A. L.
    Lelong-Boulouard, V.
    Baklouti, S.
    Goirand, F.
    Gambier, N.
    Boglione-Kerrien, C.
    Franck, B.
    Lalanne, S.
    Devresse, A.
    Briol, S.
    De Greef, J.
    Haufroid, V.
    Verdier, M.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2023, 37 : 58 - 59
  • [14] Nirmatrelvir+ritonavir/tacrolimusIncreased tacrolimus concentration following drug-drug interaction leading to various toxicities: case report
    Reactions Weekly, 2023, 1978 (1) : 291 - 291
  • [15] Recommendations for the Management of Drug-Drug Interactions Between the COVID-19 Antiviral Nirmatrelvir/Ritonavir (Paxlovid) and Comedications
    Marzolini, Catia
    Kuritzkes, Daniel R.
    Marra, Fiona
    Boyle, Alison
    Gibbons, Sara
    Flexner, Charles
    Pozniak, Anton
    Boffito, Marta
    Waters, Laura
    Burger, David
    Back, David J.
    Khoo, Saye
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 112 (06) : 1191 - 1200
  • [16] Nirmatrelvir+ritonavir/Tacrolimus interactionDrug toxicity following drug interaction
    Reactions Weekly, 2024, 2002 (1) : 379 - 379
  • [17] A CASE OF CLINICALLY SIGNIFICANT DRUG-DRUG INTERACTIONS OF PAXLOVID (NIRMATRELVIR/RITONAVIR) WITH CONCURRENT MEDICATIONS IN THE MANAGEMENT OF COVID-19
    Weill, Sydney
    Reddy, Anisha
    Bugos, Eva
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2023, 38 : S370 - S370
  • [18] Nirmatrelvir+ritonavir/tacrolimusDiarrhoea following drug-drug pharmacokinetic interaction: case report
    Reactions Weekly, 2023, 1979 (1) : 349 - 349
  • [19] Pharmacokinetics of nirmatrelvir/ritonavir and the drug-drug interaction with calcineurin inhibitor in renal transplant recipients
    Xu, Xueyin
    Zhang, Huanxi
    Liu, Longshan
    Fu, Qian
    Wu, Chenglin
    Lin, Xiaobin
    Tang, Kejing
    Wang, Changxi
    Chen, Pan
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 80 (08) : 1219 - 1227
  • [20] Paxlovid (Nirmatelvir/Ritonavir) and Tacrolimus Drug-Drug Interaction in a Kidney Transplant Patient with SARS-2-CoV infection: A Case Report
    Prikis, Marios
    Cameron, Alexandra
    TRANSPLANTATION PROCEEDINGS, 2022, 54 (06) : 1557 - 1560
12345